Latent Tuberculosis
Conditions
Keywords
Tuberculosis, Latent Tuberculosis, Texting, Adherence, Medication
Brief summary
The purpose of this pilot study is to determine whether regularly scheduled medication reminder text messages (SMS) are effective in increasing latent tuberculosis infection (LTBI) treatment completion.
Detailed description
We aim to determine the feasibility and acceptability of text reminders for improving adherence in latent TB patients. Specific objectives of the current study are to: 1) Assess the feasibility of the intervention as indicated by participant recruitment and retention and; 2) Evaluate the acceptability of the intervention, as indicated by intervention adherence, outcome measurement rates, and feedback from participants. Data will be used to design a definitive trial which will test the hypothesis that the intervention will improve medication adherence, as measured through an increase in treatment completion rates, and result in higher self-reported medication adherence, fewer missed appointments and doses, and a shorter course of treatment.
Interventions
BEHAVIORALRegularly scheduled LTBI medication reminder text messages
Regularly scheduled medication reminder text messages Daily LTBI text messages without the option to text back. The messages will read, This is a reminder to take your medication.
Sponsors
Pima County Health Department
American Lung Association
University of Arizona
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Consent to the study * Own a mobile phone which operates on a telecom provider supported by our SMS platform * Initiating or actively receiving treatment for LTBI at the Pima County TB Clinic in Tucson, AZ * Prescribed self-administered therapy * Report not having prior or current active TB disease * Know how to and are able to receive SMS messages * At least 18 years of age
Exclusion criteria
* Do not meet inclusion criteria * Do not consent to study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Recruitment | Ongoing | How many approached by clinic, how many referred, how many study eligible, how many consented; why ineligible or refused; how long to recruit each patient |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Retention | Ongoing | How many drop out at each monthly time point, who and why |
| Perceptions of Intervention through a questionnaire | Once, up to 12 months post-treatment | Perceptions and opinions (if the intervention was helpful, non-helpful, effectiveness) in the intervention arm will be assessed after the study follow-up through a questionnaire of a subset of enrolled individuals at the completion of the participant's treatment (up to 12 months post-treatment initiation). |
Countries
United States
Outcome results
None listed